Three Times Daily Dosing of UT-15C

NCT01746485 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

United Therapeutics